← Leaderboards
Jose M Silva
Cold Spring Harbor Laboratory
$4,376,541
Attributed
$4,954,347
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $586.4K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,954,347 · 5
By mechanism
R01$4,097,967 · 3
R00$743,997 · 1
K99$112,383 · 1
Top collaborators
- Jiyang Yu2 shared
Most similar at Cold Spring Harbor Laboratory
Same institution · by research overlap
- David L Spector$29,409,281
- Jonathan Sebat$25,717,433
- Andrea Schorn$2,016,000
- Grigori N Enikolopov$12,947,640
- Terri I. Grodzicker$14,352,188
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseTumorMolecularMalignant Breast NeoplasmLoss Of FunctionCellsIn VivoResistanceIn VitroCancer CellDesignLibrariesTranslatingCell DeathMalignant NeoplasmsBreast Cancer CellInnovationSmall Hairpin RnaHomeostasisSeriesCombinatorialLinkAnticancer ActivityClinical Trials
Grant awards (17)
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer$569,181
R01 · FY2025 · CA · contact PI
Investigating the Molecular Determinants Driving Response and Resistance to HDAC6 Targeted Therapy in Breast Cancer$586,431
R01 · FY2024 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$383,386
R01 · FY2020 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$371,884
R01 · FY2019 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$78,412
R01 · FY2019 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$383,386
R01 · FY2018 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$80,838
R01 · FY2018 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$383,386
R01 · FY2017 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$76,036
R01 · FY2017 · CA · contact PI
Investigating the molecular mechanism that mediates the addiction of inflammatory breast cancer cells to HDAC6 function$399,283
R01 · FY2016 · CA · contact PI
Non-cancer gene addition as anticancer strategy$259,242
R01 · FY2012 · CA · contact PI
Non-cancer gene addition as anticancer strategy$259,242
R01 · FY2011 · CA · contact PI
Non-cancer gene addition as anticancer strategy$267,260
R01 · FY2010 · CA · contact PI
Genetic approaches to next-generation breast cancer therapy$248,999
R00 · FY2010 · CA · contact PI
Genetic approaches to next-generation breast cancer therapy$247,499
R00 · FY2009 · CA · contact PI
Genetic approaches to next-generation breast cancer therapy$247,499
R00 · FY2008 · CA · contact PI
Genetic approaches to next-generation breast cancer therapy$112,383
K99 · FY2007 · CA · contact PI